0001781983 2026-04-21 2026-04-21 0001781983 1 2026-04-21 2026-04-21 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001781983 Aprea Therapeutics, Inc. N/A N/A S-3 Aprea Therapeutics, Inc. false Equity Common Stock, par value $0.001 per share true 74349426 0.92335 68650542.50 0.0001381 9480.64 68650542.50 9480.64 0.00 0.00 9480.64 The shares will be offered for resale by the selling stockholders pursuant to the prospectus contained in the Registration Statement. Represents shares of common stock and shares of common stock issuable upon exercise of outstanding warrants to purchase shares of common stock of the Company. Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares being registered in the Registration Statement include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder to prevent dilution resulting from stock splits, stock dividends, or similar transactions. Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high low sale price of the Company's common stock on April 15, 2026 as reported on The Nasdaq Stock Market LLC, which date is within five business days prior to filing the Registration Statement.